Hongwen X. Li
1 Jianshe East Road
Zhengzhou, 450000, China
Zhengzhou, 450000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Prolonged intratumoral treatment with TLR7/8 agonist R848 regulates the tumor immune microenvironment resulting in enhanced antitumor activity.
Journal: Cancer biology & therapy
Published: May 13, 2026
GNAQ inhibits tumorigenesis via the ARHGEF25-mediated RHOA pathway in NK/T-cell lymphoma.
Journal: Cancer biology & therapy
Published: December 09, 2025
Multimodal Integration in Health Care: Development With Applications in Disease Management.
Journal: Journal of medical Internet research
Published: April 26, 2025
Semaphorin 3A Confers Protection against Oxidative Stress-induced Damage in Periodontal Ligament Stem Cells through the Activation of the Wnt/β-catenin Signaling Pathway.
Journal: Current stem cell research & therapy
Published: July 12, 2024
LMP1 enhances aerobic glycolysis in natural killer/T cell lymphoma.
Journal: Cell death & disease
Published: March 11, 2024
CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma.
Journal: BMC medicine
Published: April 14, 2023
Enhanced efficacy of combined fluzoparib and chidamide targeting in natural killer/T-cell lymphoma.
Journal: Annals of hematology
Published: March 19, 2023
A second-generation CD38-CAR-T cell for the treatment of multiple myeloma.
Journal: Cancer medicine
Published: January 10, 2023
Emerging roles of the gut microbiota in cancer immunotherapy.
Journal: Frontiers in immunology
Published: January 07, 2023
Last Updated: 09/26/2026